Summary To examine the hypothesis that colorectal carcinomas with and without TP53 mutations may be characterised by aetiological heterogeneity, we analysed a group of 107 patients with primary Dukes' C colorectal cancer seen at the Memorial Sloan-Kettering Cancer Center (MSKCC) from 1986 to 1990. We assessed p53 overexpression using the monoclonal antibody PAb 1801, and identified 42 (39%) patients displaying p53-positive phenotype, defined as >25% of positive cells. Patients with two or more first-degree relatives with cancer had an odds ratio (OR) of 2.9 (95% CI 1.0-8.3) for p53 overexpression in comparison with those without a family history of cancer (trend test, P = 0.11). A possible association between body weight and p53 overexpression was observed. The ORs were 1.9 for the second quartile, 1.9 for the third quartile and 3.4 for the highest quartile in comparison with the lowest quartile (trend test, P = 0.06). No association between occupational physical activity, smoking, drinking, parity and p53 overexpression was identified. The results suggest that p53 overexpression may be related to genetic predisposition to colorectal cancer, and p53-positive and p53-negative colorectal cancers may be controlled by different aetiological pathways.
Colorectal cancer (CRC) is the second most common malignancy of both sexes in developed countries . A total of 394 000 deaths are estimated to occur annually for colorectal cancer, making it the third most important cause of cancer mortality in the world . It is also a major public health problem in the United States, with an estimated 149000 new cases diagnosed in 1994, including 107 000 of colon cancer and 42 000 of rectum cancer. The incidence ranks the third in males and the second in females in the United States (American Cancer Society, 1994) . Epidemiological studies show that increased risk of colorectal cancer may be associated with both genetic and environmental factors (Potter et al., 1993) . For the genetic component of CRC, two major types of CRC predisposition have been identified: familial adenomatous polyposis (FAP), which is believed to account for 1% of CRC cases, and hereditary non-polyposis colorectal cancer (HNPCC), which is considered to explain about 4-15% of CRC cases (Peltomaki et al., 1993 (Howe et al., 1992) and fat (Prentice et al., 1990) , have been found to play an important role in CRC risk. In addition, occupational physical activity (Vena et al., 1985) , body weight (Lee and Paffenbarger Jr., 1992; Kreger et al., 1992) , reproductive factors (La Vecchia et al., 1991) , cholecystectomy (Zeng and Zhang, 1993) , cigarette smoking (Giovannucci et al., 1994a,b) and alcohol consumption (Longnecker et al., 1990 ) have also been identified as possible risk factors.
The TP53 gene represents a broad target for mutations. Mutations at this locus are reported to be the most frequent molecular abnormalities in human cancer. The TP53 gene is associated with control of the cell cycle, DNA repair and synthesis, cell differentiation, genomic plasticity and programmed cell death (Harris, 1993; Wyllie, 1993 (Marks et al., 1991; Cunningham et al., 1992; Vahakangas et al., 1992; Dalbagni et al., 1993; Cordon-Cardo et al., 1994; Jacquemier et al., 1994) . TP53 mutational spectra can point to particular leads in the aetiology and carcinogenesis of cancer (Harris, 1993 (Kondo et al., 1992; Miller et al., 1992; Suzuki et al., 1992) , head and neck (Field et al., 1991; Brachman et al., 1992) , oesophageal (Hollstein et al., 1991) and bladder cancers (Spruck et al., 1993; Zhang et al., 1994a) . It has also been related to the ageing in prostatic adenocarcinoma (Zhang et al., 1994b) and associated with exposures to ultraviolet light in squamous cell carcinoma (Brash et al., 1991) , and to aflatoxin exposure and hepatitis B virus (Hsu et al., 1993) in hepatocellular carcinomas.
Recent reports reveal that TP53 mutations occur commonly (40-70%) in colorectal cancer (Darmon et al., 1994) . Mutations of the TP53 gene have been observed in the progression of colonic polyps to colon cancer (Vogelstein et al., 1988; Fearon and Vogelstein, 1990) . We have previously found that p53 nuclear overexpression correlates well with poor survival in colorectal cancer (Zeng et al., 1994) . Our hypothesis for the present study is that colorectal tumours with positive or negative p53 nuclear staining may be characterised by aetiological heterogeneity, which could reflect a difference in the causal pathway, or could be indicative of a difference in the magnitude of effect with the same mechanism. To test the hypothesis, we employed case series study design (Begg and Zhang, 1994) 
Materials and methods
We reviewed the medical charts of consecutive patients with colorectal cancer seen at Memorial Sloan-Kettering Cancer
Center from 1986 to 1990. Attention was restricted to primary patients with Dukes' C colorectal cancer who had potentially curative operations, regional lymph node metastases and normal preoperative serum carcinoembryonic antigen (CEA) levels (<5 ng ml-'). We studied a total of 107 (59 males, 48 females) patients with primary colorectal carcinoma. This series was previously studied for the prognostic significance of p53 in colorectal carcinoma (Zeng et al., 1994 PAb 1801 at the concentration of 200 ng 14l-I at 4°C. Sections of a breast carcinoma known to contain mutant p53 protein were used as a positive control. The specificity and accuracy of immunoreaction was checked by negative control using sections incubated with a class-matched, non-specific mouse monoclonal antibody (Mlgsl-kp-1; PharMingen, San Diego, CA, USA). Sections were rinsed in PBS and incubated with secondary biotinylated horse anti-mouse antibodies (Vector Laboratories, Burlingame, CA, USA) at 1:500 dilution, rinsed with PBS and then incubated with avidin-biotin-peroxidase complexes (Vector Laboratories) at 1:25 dilution at room temperature for 30 min. Following this, tissue sections were rinsed in PBS and immunostaining was developed by immersion in 0.06% 3,3'-diaminobenzidine tetrahydrochloride (DAB) solution dissolved in 0.5% Triton-X/PBS for 5 min. Sections were counterstained with modified Horrishaematoxylin (Fisher) and 0.3% ammonia water and passed through graded alcohols and xylene to dehydrate. Slides were then observed by conventional light microscopy.
One investigator (DSK) reviewed the slides and scored the IHC staining. In positive-staining cases, the percentage of positively stained cells (<25%, 25-50%, 50-75%, >75%) was estimated in order to determine the extent of p53 overexpression. For statistical analysis, negative or patchy (<25%) staining was considered as negative and heterogeneous or homogeneous (> = 25%) as positive. All specimens were graded using a modification of the World Health Organization classification, and staged according to the TNM pathological staging system. Epidemiological risk factors were abstracted from the charts without knowledge of the IHC results, and vice versa.
Based on the 42 cases with positive p53 and 65 cases with negative p53 the minimum detectable odds ratio with 80% power is approximately 3, so that only very strong associations would be statistically significant. Associations between p53 nuclear overexpression and exposure to potential risk factors, such as family history of cancer, body weight, occupational physical activity, cigarette smoking and drinking, were measured using the odds ratios (OR) and their 95% confidence intervals (95% CI). The odds ratios represent the ratio of the relative risk of the factors for p53-positive tumours to the relative risks of the factors for p53-negative tumours. Departures from a value of 1 may indicate aetiological heterogeneity (Begg and Zhang, 1994) . Trend tests were performed to evaluate the dose-response relationship (Breslow and Day, 1980) . In evaluating family history of cancer we first considered family history of any cancer in any relatives; then, we evaluated family history of any cancer in first-degree relatives; and, finally, we assessed the family history of a variety of individual cancer sites in the first-degree relatives. Patients with a negative family history of cancer were used as a reference group for analyses.
To assess the association between p53 overexpression and occupational physical activity, we classified the occupational titles reported by patients into one of five categories of physical activity as rated by the Department of Labor in their Estimates of Worker Trait Requirement (US Employment Service, 1956 ): (1) sedentary work, (2) light work, (3) medium work, (4) heavy work and (5) very heavy work. Over 4000 jobs defined in the Dictionary of Occupational Titles have been classified by the Department of Labor into one of five degrees of physical activity (Vena et al., 1985) . Patients whose occupational titles were coded as 'retired', 'volunteer', 'self-employed', 'unemployed' or 'homemaker' were classified into the median physical activity group (group 3).
Results

Characteristics ofpatients
Thirty-four per cent of the patients were aged less than 60 years, 35% were between the ages of 60 and 69 years and p53 and risk factors in colorectal cancer Z.F Zhang et al first-degree relatives with cancer had an odds ratio of 2.9 (95% CI 1.0-8.3) for p53 overexpression in comparison with those without family history of cancer (trend test, P=0.11) (Table II) . Patients who had a positive family history of cancer were further examined according to the tumour site in the first-degree relative. However, the data were too sparse to reveal any obvious trends.
Weight, height and body mass index (BMI) and pS3 overexpression Increased body weight was associated with p53 overexpression. The odds ratio for p53 overexpression was 3.4 (1.0-11.9) for those at the highest quartile, compared with individuals at the lowest quartile (trend test, P = 0.06). No significant relationship between height and p53 overexpression is suggested by the data (Table III) . No evidence of associations were found between p53 overexpression and smoking, drinking, occupational physical activity and parity (Table III) . CordonCardo et al., 1994) suggested that the accuracy of detecting TP53 mutation by IHC was 90.3% in human bladder cancer. Identification of p53 nuclear accumulation by IHC has also been reported to correlate well with TP53 mutations, as determined by DNA sequencing analysis in breast (Jacquemier et al., 1994 ), lung (Vahakangas et al., 1992 , and ovarian (Marks et al., 1991) cancers. Our study of colorectal cancer is disadvantaged by the fact that information on diet, the major risk factor, was unavailable because the study was retrospective, involving abstraction of data from the medical record and analysis of banked tissue specimens. The small sample size limits our ability to detect associations. But at present biomarker studies are difficult and expensive to conduct, and in context our study has a larger sample size than most other published molecular epidemiology studies (Field et al., 1991; Holstein et al., 1991; Kondo et al., 1992; Suzuki et al., 1992; Spruck et al., 1993) . Information abstracted from medical charges may be less reliable than from conventional interview studies. However, since the information on risk factors was collected by surgeons or physicians who interview patients using a standard admission history form, the potential for misclassification may be similar to conventional interview or questionnaire studies.
Family history of cancer is known to be associated with increased risk of colorectal cancer (Neugut et al., 1993) . In this study, p53-positive tumours occur 2.9 times more frequently in patients with two or more first-degree relatives with cancer. After controlling for body weight, the odds ratio was 3.0 (1.0-9.2). Our findings indicate that p53 overexpression may be related to genetic predisposition in colorectal cancer. It is possible that germline mutations may be present in the TP53 gene in some high-risk families, and that this is responsible for the association observed in our study.
Increased body weight has also been identified as a possible risk factor (Kreger et al., 1992; Lee and Paffenbarger Jr., 1992) . We found that the odds ratio of p53 overexpression was 3.4 for individuals at the highest quartile of body weight compared with those at the lowest quartile. The odds ratio was 3.1 (0.9-11.4) when adjusting for first-degree family members with cancer. The mechanism for the relationship between body weight and the risk of colorectal cancer is obscure. Increased body weight may be related to increased fat or caloric intake, decreased physical activity and metabolic and hormonal changes owing to increased body fat (Neugut et al., 1993) . Body weight correlates to dietary fat intake. In animals, high intake of dietary fat stimulates the secretion of bile and fatty acids. Increased concentration of bile and fatty acids in the colon may damage the surface epithelium of the colon, which in turn stimulates the replication of colonic epithelial cells (Lee and Paffenbarger Jr., 1992) . Since a high proportion of transition-type point mutations of the TP53 gene have been found in human colon cancers, the association between increased body weight and p53 overexpression may, in part, be due to those endogenous determinants involved in carcinogenesis (Harris, 1993; Renault et al., 1993) .
We assessed the relationship between occupational physical activity and p53 overexpression and found no association. Since the occupational information obtained from the medical charts was the last occupation or the occupation at admission, our data may not accurately reflect lifetime occupational activity. We observed no apparent association between p53 overexpression and cigarette smoking in colorectal cancer in contrast to our earlier study of bladder cancer (Zhang et al., 1994a) .
We have shown that the odds ratio relating risk factors to the presence of a biological marker is an appropriate measure for characterising the degree of aetiological heterogeneity between the disease groupings defined by the biomarker (Begg and Zhang, 1994) . In this study, we found that in patients with two or more first-degree members with cancer and those with high body weights had higher prevalence of p53 overexpression, which indicates that p53 overexpression may be related to genetic predisposition to colorectal cancer, and p53-positive and -negative colorectal cancers may be controlled by different aetiological pathways.
